echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Henan Enlargement Recruitment: Collecting 6 varieties of flow standards, purchasing more than 200 million

    Henan Enlargement Recruitment: Collecting 6 varieties of flow standards, purchasing more than 200 million

    • Last Update: 2022-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    At present, Henan has notified the provincial procurement of standard varieties: 6 standard varieties, and the purchase amount exceeds 200 million in four and a half months
    .
    The hospitals are required to explain the reasons in the medical records.
    If the reasons are not explained, the medical insurance fund will not pay
    .
    During the same period, the provincial centralized procurement of similar alternative varieties (non-medical insurance) totaled 190 million yuan
    .
     
    On February 21, Henan Province issued the "Notice on the Procurement and Use of Non-Medical Insurance Varieties in the Province's Centralized Procurement of Flow-Standard Varieties (First Batch) and the First Batch of Provincially Procured Similar Substitute Catalogues " .
     
    Previously (October 29, 2021), the Henan Provincial Bureau issued the "Notice on Matters Concerning the Reference Monitoring Scope of Alternative Drugs for Centralized Procurement of Varieties in the State and Our Province" (Yu Medical Insurance Office [2021] No.
    64), requiring Medical security departments at all levels and designated medical institutions conduct key monitoring on completely substitutable varieties, non-medical insurance varieties, and provincial centralized collection and flow standard varieties within the scope of monitoring;
     
    Among them, the non-medical insurance varieties within the monitoring range can be substituted, and the medical insurance fund will not pay; in the case of the supply of selected drugs in the same centralized procurement with volume, medical institutions really need to use the completely replaceable varieties within the monitoring scope and the province's centralized procurement with volume For the varieties that fail the standard, the reasons must be explained in the medical records.
    If the reasons are not explained, the medical insurance fund will not pay
    .
     
    From November 1, 2021 to February 15, 2022, medical institutions in Henan Province will purchase and use the non-medical insurance varieties in the centralized and volume-purchased standard varieties (the first batch) and the first batch of provincially-purchased drugs of the same kind.
    Procurement and usage will be notified
    .
     
    The notice requires local and municipal medical insurance bureaus to investigate medical institutions within their jurisdictions and provincial medical insurance service centers to investigate provincially-managed public medical institutions; to collect the hospitalized medical records of patients from November 1, 2021 to February 15, 2022, and find problems according to The "Notice on Matters Concerning the Reference Monitoring Scope of Alternative Drugs for Centralized Procurement of Varieties by the State and Our Province" (Yu Medical Insurance Office [2021] No.
    64) shall be dealt with, and relevant medical personnel shall be held accountable if necessary
    .
     
      Before March 10, 2022, the processing results of the medical institutions involved in the jurisdiction will be summarized and submitted to the Provincial Bureau of Pricing
    .
    If major problems are found during the investigation, report to the provincial bureau in a timely manner
    .

     
      According to the attached table of the notice, there are a total of 6 varieties of flow-standard varieties (the first batch) in Henan Province, which are:
     
      1.
    Ranitidine (injection)
     
      2.
    Ilaprazole (oral normal-release dosage form)
     
      3.
    Niacin (injection)
     
      4.
    Niacin (oral normal release dosage form)
     
      5.
    Succinyl gelatin (injection)
     
      6.
    Granisetron (oral normal release dosage form)
     
      From 2021.
    11.
    1 to 2.
    15, the total purchase amount of Henan Province’s centralized procurement of flow-standard varieties (the first batch) is 206 million yuan, and the storage amount is 170 million yuan, involving 4,305 records
    .
     
      During the same period, judging from the procurement and use of similar alternative varieties (non-medical insurance) in Henan Province, the total purchase amount was 190 million yuan, and the storage amount was 160 million yuan, involving 15,561 records
    .
     
      Previously (December 17, 2021), Henan announced the first five batches of national centralized collection varieties of alternative medicine reference monitoring ranges, and issued the first batch of Henan Province-collected varieties of alternative medicine reference ranges, as follows:
     
      At present, Henan has notified the provincial procurement of standard varieties: 6 standard varieties, and the purchase amount exceeds 200 million in four and a half months
    .
    The hospitals are required to explain the reasons in the medical records.
    If the reasons are not explained, the medical insurance fund will not pay
    .
    During the same period, the provincial centralized procurement of similar alternative varieties (non-medical insurance) totaled 190 million yuan
    .
     
      On February 21, Henan Province issued the "Notice on the Procurement and Use of Non-Medical Insurance Varieties in the Province's Centralized Procurement of Flow-Standard Varieties (First Batch) and the First Batch of Provincially Procured Similar Substitute Catalogues " .
     
      Previously (October 29, 2021), the Henan Provincial Bureau issued the "Notice on Matters Concerning the Reference Monitoring Scope of Alternative Drugs for Centralized Procurement of Varieties in the State and Our Province" (Yu Medical Insurance Office [2021] No.
    64), requiring Medical security departments at all levels and designated medical institutions conduct key monitoring on completely substitutable varieties, non-medical insurance varieties, and provincial centralized collection and flow standard varieties within the scope of monitoring;
     
      Among them, the non-medical insurance varieties within the monitoring range can be substituted, and the medical insurance fund will not pay; in the case of the supply of selected drugs in the same centralized procurement with volume, medical institutions really need to use the completely replaceable varieties within the monitoring scope and the province's centralized procurement with volume For the varieties that fail the standard, the reasons must be explained in the medical records.
    If the reasons are not explained, the medical insurance fund will not pay
    .
     
      From November 1, 2021 to February 15, 2022, medical institutions in Henan Province will purchase and use the non-medical insurance varieties in the centralized and volume-purchased standard varieties (the first batch) and the first batch of provincially-purchased drugs of the same kind.
    Procurement and usage will be notified
    .
     
      The notice requires local and municipal medical insurance bureaus to investigate medical institutions within their jurisdictions and provincial medical insurance service centers to investigate provincially-managed public medical institutions; to collect the hospitalized medical records of patients from November 1, 2021 to February 15, 2022, and find problems according to The "Notice on Matters Concerning the Reference Monitoring Scope of Alternative Drugs for Centralized Procurement of Varieties by the State and Our Province" (Yu Medical Insurance Office [2021] No.
    64) shall be dealt with, and relevant medical personnel shall be held accountable if necessary
    .
     
      Before March 10, 2022, the processing results of the medical institutions involved in the jurisdiction will be summarized and submitted to the Provincial Bureau of Pricing
    .
    If major problems are found during the investigation, report to the provincial bureau in a timely manner
    .

     
      According to the attached table of the notice, there are a total of 6 varieties of flow-standard varieties (the first batch) in Henan Province, which are:
     
      1.
    Ranitidine (injection)
     
      2.
    Ilaprazole (oral normal-release dosage form)
     
      3.
    Niacin (injection)
     
      4.
    Niacin (oral normal release dosage form)
     
      5.
    Succinyl gelatin (injection)
     
      6.
    Granisetron (oral normal release dosage form)
     
      From 2021.
    11.
    1 to 2.
    15, the total purchase amount of Henan Province’s centralized procurement of flow-standard varieties (the first batch) is 206 million yuan, and the storage amount is 170 million yuan, involving 4,305 records
    .
     
      During the same period, judging from the procurement and use of similar alternative varieties (non-medical insurance) in Henan Province, the total purchase amount was 190 million yuan, and the storage amount was 160 million yuan, involving 15,561 records
    .
     
      Previously (December 17, 2021), Henan announced the first five batches of national centralized collection varieties of alternative medicine reference monitoring ranges, and issued the first batch of Henan Province-collected varieties of alternative medicine reference ranges, as follows:
     
      At present, Henan has notified the provincial procurement of standard varieties: 6 standard varieties, and the purchase amount exceeds 200 million in four and a half months
    .
    The hospitals are required to explain the reasons in the medical records.
    If the reasons are not explained, the medical insurance fund will not pay
    .
    During the same period, the provincial centralized procurement of similar alternative varieties (non-medical insurance) totaled 190 million yuan
    .
     
      On February 21, Henan Province issued the "Notice on the Procurement and Use of Non-Medical Insurance Varieties in the Province's Centralized Procurement of Flow-Standard Varieties (First Batch) and the First Batch of Provincially Procured Similar Substitute Catalogues " .
    Procurement of medicines and medicines _
     
      Previously (October 29, 2021), the Henan Provincial Bureau issued the "Notice on Matters Concerning the Reference Monitoring Scope of Alternative Drugs for Centralized Procurement of Varieties in the State and Our Province" (Yu Medical Insurance Office [2021] No.
    64), requiring Medical security departments at all levels and designated medical institutions conduct key monitoring on completely substitutable varieties, non-medical insurance varieties, and provincial centralized collection and flow standard varieties within the scope of monitoring;
     
      Among them, the non-medical insurance varieties within the monitoring range can be substituted, and the medical insurance fund will not pay; in the case of the supply of selected drugs in the same centralized procurement with volume, medical institutions really need to use the completely replaceable varieties within the monitoring scope and the province's centralized procurement with volume For the varieties that fail the standard, the reasons must be explained in the medical records.
    If the reasons are not explained, the medical insurance fund will not pay
    .
     
      From November 1, 2021 to February 15, 2022, medical institutions in Henan Province will purchase and use the non-medical insurance varieties in the centralized and volume-purchased standard varieties (the first batch) and the first batch of provincially-purchased drugs of the same kind.
    Procurement and usage will be notified
    .
     
      The notice requires local and municipal medical insurance bureaus to investigate medical institutions within their jurisdictions and provincial medical insurance service centers to investigate provincially-managed public medical institutions; to collect the hospitalized medical records of patients from November 1, 2021 to February 15, 2022, and find problems according to The "Notice on Matters Concerning the Reference Monitoring Scope of Alternative Drugs for Centralized Procurement of Varieties by the State and Our Province" (Yu Medical Insurance Office [2021] No.
    64) shall be dealt with, and relevant medical personnel shall be held accountable if necessary
    .
     
      Before March 10, 2022, the processing results of the medical institutions involved in the jurisdiction will be summarized and submitted to the Provincial Bureau of Pricing
    .
    If major problems are found during the investigation, report to the provincial bureau in a timely manner
    .

     
      According to the attached table of the notice, there are a total of 6 varieties of flow-standard varieties (the first batch) in Henan Province, which are:
     
      1.
    Ranitidine (injection)
      
     
      2.
    Ilaprazole (oral normal-release dosage form)
     
      3.
    Niacin (injection)
     
      4.
    Niacin (oral normal release dosage form)
     
      5.
    Succinyl gelatin (injection)
     
      6.
    Granisetron (oral normal release dosage form)
     
      From 2021.
    11.
    1 to 2.
    15, the total purchase amount of Henan Province’s centralized procurement of flow-standard varieties (the first batch) is 206 million yuan, and the storage amount is 170 million yuan, involving 4,305 records
    .
     
      During the same period, judging from the procurement and use of similar alternative varieties (non-medical insurance) in Henan Province, the total purchase amount was 190 million yuan, and the storage amount was 160 million yuan, involving 15,561 records
    .
     
      Previously (December 17, 2021), Henan announced the first five batches of national centralized collection varieties of alternative medicine reference monitoring ranges, and issued the first batch of Henan Province-collected varieties of alternative medicine reference ranges, as follows:
     
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.